BVF PARTNERS L P/IL
CIK 1055947 · last filed 2025-07-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MRUS price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
40TH FLOOR
SAN FRANCISCO, CA 94104
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KYMR | Director | 353,412 | $113.80 | $40.22M | $139.55M | 1 | 2025-07-01 |
| PVLA | 282,223 | $126.40 | $35.67M | $0 | 1 | 2024-12-17 | |
| MLTX | Director | 9,005,700 | $11.74 | $105.77M | $0 | 1 | 2024-06-10 |
| ELDN | 10%+ Owner | 3,361,803 | $2.23 | $7.50M | $0 | 1 | 2024-05-13 |
| XOMA Royalty Corp (XOMAP) Delisted | Director | 1,556,696 | $24.98 | $38.89M | $0 | 1 | 2022-05-20 |
| RAIN | Director | 1,367,838 | $0.57 | $785.8K | $266.23M | 3 | 2022-01-10 |
| Merus N.V. (MRUS) Delisted | 10%+ Owner | 1,578,732 | $90.00 | $142.09M | -$290.16M | 3 | 2021-10-08 |
| OLMA | Director | 535,638 | $6.62 | $3.55M | $0 | 1 | 2021-05-26 |
| INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | 10%+ Owner | 3,279,831 | $0.04 | $146.6K | $1.47M | 2 | 2021-02-19 |
| CTMX | 358,450 | $2.18 | $780.0K | $0 | 1 | 2021-02-18 | |
| XOMA Royalty Corp (XOMA) Delisted | 10%+ Owner | 2,194,410 | $40.17 | $88.15M | $1.20M | 1 | 2020-08-20 |
| FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | 10%+ Owner | 346,627 | $38.00 | $13.17M | $4.44M | 1 | 2019-10-25 |
| CTI BIOPHARMA CORP (CTIC) Delisted | 10%+ Owner | 2,734,725 | $9.09 | $24.86M | $8.53M | 2 | 2017-06-14 |
| ALPINE IMMUNE SCIENCES, INC. (NVLS) Delisted | 10%+ Owner | 274,882 | — | — | $1.16M | 1 | 2017-06-07 |
| Cascadian Therapeutics, Inc. (ONTY) Delisted | 10%+ Owner | 3,298,293 | — | — | $5.57M | 2 | 2014-12-17 |
| Tobira Therapeutics, Inc. (RGDO) Delisted | 124,580 | — | — | $0 | 1 | 2014-03-25 | |
| PTN | 10%+ Owner | 17,525 | $4.93 | $86.4K | -$5.62M | 2 | 2014-03-03 |
| CCXI | 10%+ Owner | 2,079,532 | $10.24 | $21.29M | $10.51M | 3 | 2013-12-05 |
| LGND | 10%+ Owner | 4,506,145 | $308.45 | $1.39B | -$46.58M | 7 | 2013-01-25 |
| NBIX | 10%+ Owner | 6,658,212 | $144.81 | $964.18M | -$8.66M | 4 | 2012-02-10 |
| ICAGEN INC (ICGN) Delisted | 10%+ Owner | 219,700 | — | — | $4.56M | 1 | 2011-09-09 |
| CAPS | 10%+ Owner | 27 | $2.66 | $72 | $149.9K | 1 | 2011-06-29 |
| Celera CORP (CRA) Delisted | 10%+ Owner | 18,772,784 | — | — | $8.96M | 1 | 2011-04-07 |
| RPRX | 10%+ Owner | 2,297,776 | $65.04 | $149.45M | -$4.03M | 1 | 2009-09-21 |
| DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | 10%+ Owner | 855,770 | $15.50 | $13.26M | -$20.11M | 1 | 2009-09-11 |
| EPIRUS Biopharmaceuticals, Inc. (CRXX) Delisted | 10%+ Owner | 8,459,999 | — | — | $181.2K | 3 | 2008-12-05 |
Recent Filings · Page 5 of 6
56 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-04-07 | Celera CORP (CRA) Delisted | Buy (P) | +1,092,000 | $8.96M | EDGAR |
| 2010-03-29 | NBIX | Sell (S) | −2,478,600 | -$6.69M | EDGAR |
| 2010-03-24 | NBIX | Sell (S) | −1,134,000 | -$3.13M | EDGAR |
| 2009-09-21 | RPRX | Sell (S) | −2,412,000 | -$4.03M | EDGAR |
| 2009-09-11 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Sell (S) | −7,272,636 | -$20.11M | EDGAR |
| 2009-08-26 | LGND | Sell (S) | −27,315,300 | -$70.20M | EDGAR |
| 2009-07-16 | — | Buy (P) | +57,096 | $171.0K | |
| 2009-07-06 | LGND | Sell (S) | −856,200 | -$2.54M | EDGAR |
| 2008-12-05 | EPIRUS Biopharmaceuticals, Inc. (CRXX) Delisted | Buy (P) | +118,500 | $64.4K | EDGAR |
| 2008-12-03 | LGND | Buy (P) | +1,623,500 | $3.06M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.